{"entity":{"id":"nct05908643","kind":"trial","name":"A First-In-Human Trial of pTTL in Advanced Colorectal Cancer","aka":[],"tldr":"A phase 1/2 trial of pTTL in colorectal cancer, run by Neogap Therapeutics AB, now recruiting.","summary":"A First-In-Human Trial of pTTL in Advanced Colorectal Cancer is a phase 1/2 interventional study registered as NCT05908643 by Neogap Therapeutics AB, with 16 participants planned, started 2023-03-15 and due to reach its primary completion in 2027-12. Interventions recorded: pTTL.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05908643","url":"https://clinicaltrials.gov/study/NCT05908643"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05908643","phase":"1/2","setting":"A First-In-Human, Phase I/IIa Trial of the Novel T Cell Immunotherapy pTTL in Patients With Advanced Colorectal Cancer","sponsor":"Neogap Therapeutics AB","participation":[{"nct":"NCT05908643","source":"https://clinicaltrials.gov/study/NCT05908643","fetchedAt":"2026-10-07T16:54:00.715Z","studySha256":"c7758f411aa25488b02630b38e567ecd23dc25e1214840f3a7f7b7f97e797eb8","overallStatus":"RECRUITING","lastUpdatePosted":"2025-05-29","leadSponsor":"Neogap Therapeutics AB","collaboratorCount":4,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":16,"enrolmentType":"ESTIMATED","siteCount":2,"recruitingSiteCount":2,"countries":["Sweden"]}],"started":"2023-03-15","startedType":"actual","enrolled":16,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05908643/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}]}}